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the sample was deposited on an agar
plate flooded with a suspension of a
antimicrobial susceptible strain of
Micrococcus luteus. After 24 h of
incubation at 37°C, presence of
antimicrobial activity in the sample
was evident by a visible area of
growth inhibition of M. luteus around
the sample. Procedures for DNA
extraction and16S rRNA gene ampli-
fication and sequencing have been
detailed (4).
Gram staining of the sample
showed numerous polymorpho-
nuclear leukocytes and gram-negative
bacteria. Culture of the sample
remained sterile after 20 days of incu-
bation, and antimicrobial susceptibili-
ty was found. The 16S rRNA gene
amplification and sequencing deter-
mined a 1,493 nucleotide sequence.
This sequence had 99.7% nucleotide
similarity with that of L. amnionii
(GenBank accession no. AY078425),
which corresponded to a difference of
4 nucleotide. The 16S rRNA gene
sequence of the detected bacterium
was deposited under accession no.
AY489565. L. amnionii was previous-
ly recovered in anaerobic culture of
the amniotic fluid of a woman after
intrauterine fetal demise (2). It was
isolated on blood and chocolate agar
under anaerobic conditions and
showed very small gray colonies of
<1 mm. This slow-growing bacterium
was lost after two subcultures, and no
isolate is available for further descrip-
tion (2). In that case and in the case
reported here, the patients had
uneventful recoveries after an amoxi-
cillin plus clavulanic acid antimicro-
bial regimen was given. This bacteri-
um and our isolate are related to, but
different from, L. sanguinegens.
Leptotrichia is a small genus
closely related to Fusobacterium and
comprises slow-growing, gram-nega-
tive, filamentous, anaerobic bacterial
flora of the oral cavity and genital
tract (5). Species included in the
genus are L. buccalis, L. trevisanii, L.
sanguinegens, and L. amnionii (2,6).
All Leptotrichia species are extremely
fastidious and cannot be grown easily
on conventional microbiologic media
or by conventional methods. As evi-
denced by sequences available in the
GenBank database, most of the 16S
rRNA gene sequences are from
cloned DNA from complex flora but
not from bacterial isolates.
Leptotrichia species has been suspect-
ed to play a role in periodontal dis-
ease. However, Leptotrichia species
have only been associated with seri-
ous systemic disease, usually in
immunocompromised patients (7,8).
Bacteremia caused by L. sanguine-
gens in pregnant women has also been
reported (9). More widespread use of
polymerase chain reaction amplifica-
tion and sequencing of the 16S rRNA
gene for identification or detection of
fastidious pathogens in humans will
likely provide verification of several
new pathogens that are now part of
normal human flora. 
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Cholera in
Mozambique,
Variant of Vibrio
cholerae
To the Editor: Cholera outbreaks
caused by toxigenic Vibrio cholerae
serogroup O1 frequently occur in
many sub-Saharan African countries.
The serogroup O1 is classified into
two biotypes, classical and El Tor.
The seventh and current pandemic of
cholera is caused by the El Tor bio-
type; the classical biotype is believed
to be extinct. The classical and El Tor
biotypes of V. cholerae O1 are closely
related in their O-antigen biosynthetic
genes but differ in other regions of the
genome. The genomic structure of the
CTXΦ filamentous phage (1), in
which the cholera toxin genes are con-
tained, differs between the classical
and El Tor biotypes. CTXclassΦ is
found in classical strains, CTXETΦ is
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present in El Tor and O139 strains,
and CTXcalcΦ is found in resurgent
O139 strains. The diversity of CTXΦ
among biotypes is mainly due to the
variations in the repeat sequence ele-
ments, particularly in the rstR gene
region (2).
While conducting surveillance in
the cholera treatment center in Beira,
the second largest city in
Mozambique, we examined 175 rectal
swabs or stool samples from January
7 to March 8, 2004, using standard
published procedures. During this
period, we isolated 58 strains of V.
cholerae O1. The isolates were trans-
ported to the Enteric Microbiology
Unit of the International Center for
Diarrhoeal Disease Research in
Dhaka, Bangladesh (ICDDRD,B), for
further phenotypic and genotypic
characterization to determine
serotype, biotype, and presence of
important virulence genes. All 58
strains were identified as V. cholerae
O1 of the Ogawa serotype. Forty
strains selected for detailed character-
ization were resistant to polymyxin B,
agglutinated chicken cells, yielded a
positive Voges-Proskauer reaction,
were positive for the El Tor hemolysin
by the tube agglutination method, and
were sensitive to group IV El Tor
phage but resistant to the classical
group V phage and were therefore
classified as the El Tor biotype. The
antimicrobial susceptibility of 15 of
the 40 isolates examined showed that
the strains were sensitive to tetracy-
cline, ampicillin, furazolidone,
erythromycin, and ciprofloxacin but
resistant to trimethoprim-sulfame-
thoxazole, and also to the vibriostatic
compound 0/129.
By using polymerase chain reac-
tion (PCR), we established that all 40
strains carried the ctxA gene (con-
stituent gene of the CTX prophage)
and the tcpA gene (the El Tor type), a
constituent gene of the vibrio patho-
genicity island. We then focused on
the rstR gene because of its diversity
between the two biotypes. All of the
40 El Tor strains produced a 500-bp
PCR product of the rstR gene of the
classical type (rstRclass), despite
belonging to the El Tor biotype.
Nucleotide sequence analysis of the
rstR gene of two representative
Mozambique strains showed 100%
homology to the classical rstR gene of
classical reference strain O395. The
amino acid sequence of the B-subunit
of classical and El Tor biotypes have
distinct signature sequences (3). We
amplified the ctxB gene using specific
primers and found that the deduced
amino acid sequence of the CT-B sub-
unit of the Mozambique strains varied
from the El Tor CT-B subunit at posi-
tions 39 (histidine replaces tyrosine in
El Tor) and 68 (threonine replaces
isoleucine in El Tor), and the amino
acid residues at these positions are
identical to those of the classical CT-
B subunit (Figure). The nucleotide
sequences obtained for ctxB of the
two Mozambique strains B33 and
B65 were deposited in GenBank
under accession no. AY648939 and
AY6448940, respectively. Therefore,
the Mozambique strains of V. choler-
ae O1 displayed typical traits of the El
Tor biotype overall but carried the
classical CTX prophage.
Our findings that El Tor strains of
V. cholerae O1 from Mozambique are
carrying the classical prophage shows
the presence of genetic materials
associated with the classical biotype
in Mozambique. Further, these find-
ings provide the first circumstantial
evidence of transmission of the classi-
cal CTX prophage. The CTX
prophages in El Tor strains give rise to
infectious phage particles (1), but nei-
ther of the two CTX prophages inte-
grated at two different sites of the
classical genome give rise to phage
particles (4). Subsequent studies have
shown that, although the genes of the
classical prophages encode functional
forms of all of the proteins needed for
production of CTXΦ, the CTX
prophage does not yield virions
because of the atypical arrangement
of its prophage arrays (4).
Genetic hybrids between El Tor
and classical biotypes of O1 V. choler-
ae were reported among sporadic iso-
lates earlier in Bangladesh (5) and
were named the Matlab variants after
the place where they were first isolat-
ed. The Mozambique strains of V.
cholerae likely evolved from an El
Tor strain, which shed its CTX phage
and acquired the classical prophage.
Alternatively, strains like the Matlab
variant may have spread to the
African subcontinent. Whether intro-
ducing the CTX prophage in the El
Tor genome background will increase
pathogenicity, affect genomic stabili-
ty, or enhance the epidemic-causing
potential is uncertain. This subtle
genetic change might also alter the
effectiveness of current cholera vac-
cines which stimulate antitoxic as
well as antibacterial immunity. 
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Figure: Amino acid sequence alignment of CT-B subunit of Vibrio cholerae O1 classical,
El Tor, and Mozambique (B33 and B65) strains. Identical amino acid residues are indicat-
ed by a period. Amino acid sequences of CtxB of V. cholerae classical (AAL60524.1;
AAM47189.1) and El Tor (AAM74192.1; AAM77066.1) are from GenBank.LETTERS
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Instructions for Emerging
Infectious Diseases Authors
Letters 
Letters commenting on recent arti-
cles as well as letters reporting
cases, outbreaks, or original
research are welcome. Letters com-
menting on articles should contain
no more than 300 words and 5 ref-
erences; they are more likely to be
published if submitted within 4
weeks of the original article's publi-
cation. Letters reporting cases, out-
breaks, or original research should
contain no more than 800 words
and 10 references. They may have
one Figure or Table and should not
be divided into sections. All letters
should contain material not previ-
ously published and include a word
count.
Correction, vol. 10, no. 10
In "Scrub Typhus in the Republic of Palau, Micronesia," by A.
Mark Durand et al. (p. 1840), Table 2 was incorrect. The correct version
appears below and online at http://www.cdc.gov/ncidod//eid/vol10no10/
04-0288.htm#table2. We regret any confusion this error may have
caused.
Use of trade names is for identification
only and does not imply endorsement by
the Public Health Service or by the U.S.
Department of Health and Human
Services.